Linagliptin Add-on to Insulin Background Therapy
Condition(s):Diabetes Mellitus, Type 2Last Updated:March 25, 2020Completed
Hide Studies Not Open or Pending
Condition(s):Diabetes Mellitus, Type 2Last Updated:March 25, 2020Completed
Condition(s):Diabetes Mellitus Type 2Last Updated:December 14, 2023Active, not recruiting
Condition(s):Type 2 DiabetesLast Updated:May 2, 2019Completed
Condition(s):Diabetes Mellitus, Non-Insulin-Dependent; Heart FailureLast Updated:March 30, 2020Completed
Condition(s):Diabetes Mellitus; Iron Metabolism Disorders; Gastroduodenal Ulcer; Optic Atrophy; Sensorineural Hearing Loss; Platelet DysfunctionLast Updated:August 29, 2016Unknown status
Condition(s):PreTerm BirthLast Updated:November 21, 2017Completed
Condition(s):Acute Heart FailureLast Updated:January 5, 2021Completed
Condition(s):T-cell Type Acute Leukemia-Precursor; T-lymphoblastic Lymphoma/LeukaemiaLast Updated:March 21, 2022Terminated
Condition(s):Hepatitis CLast Updated:August 25, 2023Completed
Condition(s):Liver Dysfunction; Hepatectomy; Bilirubinaemia; JaundiceLast Updated:June 10, 2021Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.